Lv3
213 积分 2020-08-03 加入
Addition of ipilimumab to atezolizumab plus bevacizumab in advanced hepatocellular carcinoma (PRODIGE 81-FFCD 2101-TRIPLET HCC): phase 2 results from a randomised, multicentre, open-label, phase 2–3 trial
12小时前
求助中
Amycretin, a novel, unimolecular GLP-1 and amylin receptor agonist administered subcutaneously: results from a phase 1b/2a randomised controlled study
2个月前
已完结
GLP-2 prevents antipsychotics-induced metabolic dysfunction in mice
2个月前
已完结
The effects of a soluble activin type IIB receptor on obesity and insulin sensitivity
2个月前
已完结
Revisiting energy expenditure: how to correct mouse metabolic rate for body mass
2个月前
已完结
Systematic profiling of tumor-associated antigen expression for antibody-drug conjugate in prostate cancer
2个月前
已完结
Therapeutic landscape of metabolic dysfunction-associated steatohepatitis (MASH)
3个月前
已完结
Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
3个月前
已完结
Hepatic GPR110 contributes to sex disparity in the development of MASH through oestrogen receptor α-dependent signalling
3个月前
已完结
1616-P: Effect of Mazdutide on MASH Fibrosis—Targeting the Liver–Gut Axis and Microbiome
3个月前
已完结
皖公网安备34019202002308
